Current Managing Director of B. Braun U.K. Michael Parden will assume the North American CEO position on May 1, 2026.

With Jammu and Kashmir’s fertility rate falling to an all-time low of 1.4, well below replacement level, every birth has ...

According to Towards Packaging consultants, the global paper-based barrier market is projected to reach approximately USD ...

Novo Nordisk has asked the FDA to stop compounding pharmacies making cheaper versions of its semaglutide-based therapies for obesity and diabetes, saying the drug is too complex to be made safely by ...

The FDA has said it has agreed to reconsider its decision to prevent compounding pharmacies from producing and selling versions of Eli Lilly's diabetes and obesity drug tirzepatide. The US regulator ...